We are live on
!
Find out more
CPX
Canaan Partners XI Portfolio holdings
AUM
$127M
1-Year Est. Return
217.49%
This Fund
S&P 500
This Quarter
Est. Return
+44.2%
1 Year Est. Return
+217.49%
3 Year Est. Return
+1,311.52%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$118M
AUM Growth
+$35.5M
(+43%)
Cap. Flow
-$179K
Cap. Flow
% of AUM
-0.15%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
3
New
–
Increased
–
Reduced
1
Closed
–
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rallybio
RLYB
|
+$179K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 89.7% |
| 2 | Technology | 10.3% |
Similar funds
CF
MF
SAP
S
PIP
VDC
SIM
PC
Canaan Partners XI's Q3 2024 Portfolio in Review
As of Q3 2024, Canaan Partners XI held 3 positions worth $118M, up 43% from $82.6M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Trading was light in Q3 2024: portfolio turnover was 0%. Canaan Partners XI opened no new positions and made no exits, leaving the 3-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 90% of assets, up from 89% a quarter earlier, followed by Technology.
- Canaan Partners XI's biggest Q3 2024 reduction was Rallybio, cutting an estimated $179K.
- Canaan Partners XI's ten largest holdings make up 100% of its $118M portfolio in Q3 2024.
- Canaan Partners XI opened 0 new positions and closed 0 in Q3 2024.
- Canaan Partners XI's portfolio value rose 43% quarter-over-quarter to $118M.
Based on Canaan Partners XI's 13F filing for Q3 2024, filed 16 Oct 2024.